Monoclonal Antibodies, Explained

Primary Viewpoints: Immunizations with Dr Steven P. Furr

The data, published in JASN, were presented last week to an FDA advisory committee considering recommending sotagliflozin as an adjunct to insulin in adults with T1D and CKD.

Keith A. Reynolds

October 1st 2024

When is It Time to Refer? A Dermatologist Considers Atopic Dermatitis Treated in Primary Care

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Up to 80% of atopic dermatitis is managed in primary care but some patients will need a higher level of care. Dr Mona Shahriari discusses factors that point to referral.

October 25th 2023

New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

FIT Completion Rates Back Screening for CRC at Age 45: Daily Dose

SYNCHRONIZE-1 and -2 will provide "robust evidence" on the safety, efficacy, and tolerability of survodutide in adults with obesity with or without T2D.

Data Published on Sotagliflozin Used to Reduce HbA1c in Adults with Type 1 Diabetes and Kidney Disease

Your daily dose of the clinical news you may have missed.

Related Content

Primary Viewpoints: Immunizations with Dr Steven P. Furr

The data, published in JASN, were presented last week to an FDA advisory committee considering recommending sotagliflozin as an adjunct to insulin in adults with T1D and CKD.

Keith A. Reynolds

October 1st 2024

When is It Time to Refer? A Dermatologist Considers Atopic Dermatitis Treated in Primary Care

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Up to 80% of atopic dermatitis is managed in primary care but some patients will need a higher level of care. Dr Mona Shahriari discusses factors that point to referral.

October 25th 2023

New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

FIT Completion Rates Back Screening for CRC at Age 45: Daily Dose

SYNCHRONIZE-1 and -2 will provide "robust evidence" on the safety, efficacy, and tolerability of survodutide in adults with obesity with or without T2D.